CVS Ventures | Activity

Investment

Participated in Oshi Health's $30M Series B for virtual multidisciplinary digestive care.

Oshi Health

Oshi Health CVS Ventures

oshihealth.com

Added recently

Investment

Participated in Main Street Health's $315M round for value-based care scaling in rural America.

Main Street Health

Main Street Health CVS Ventures

medcitynews.com

Added recently

Milestone

Portfolio company Thyme Care achieved unicorn status in 2025, becoming CVS Health Ventures' most recent unicorn.

Thyme Care

Thyme Care CVS Ventures

tracxn.com

Added recently

Investment

Strategic investment in Fathom, an autonomous medical coding platform achieving 90%+ automation rates across specialties.

Fathom

Fathom CVS Ventures

businesswire.comMAY 4, 2026

MAY 4, 2026

Investment

Participated in Big Health's $23.7M round for FDA-cleared digital therapeutics including SleepioRx and DaylightRx.

Big Health

Big Health CVS Ventures

bhbusiness.comFEB 12, 2026

FEB 12, 2026

Investment

Led Knownwell's oversubscribed $25M round to scale its weight-inclusive primary care and obesity medicine model nationwide.

Knownwell

Knownwell CVS Ventures

businesswire.comOCT 20, 2025 axios.com

OCT 20, 2025

Exit

Portfolio company Thirty Madison acquired by Remedy Meds for $500M.

Thirty Madison

Thirty Madison CVS Ventures

tracxn.comSEP 2025

SEP 2025

Investment

Led AmplifAI's $33.7M Series B for AI-powered contact center performance platform.

AmplifAI

AmplifAI CVS Ventures

amplifai.comSEP 2025

SEP 2025

Investment

Strategic investment in Amalgam Rx for patient and provider decision-making support.

Amalgam Rx

Amalgam Rx CVS Ventures

businesswire.comOCT 2023

OCT 2023

Investment

Participated in Strive Health's $166M Series C for value-based kidney disease care.

Strive Health

Strive Health CVS Ventures

strivehealth.comOCT 2023

OCT 2023

Investment

Led Cortica's $40M Series D extension for doctor-led autism care services.

Cortica Care

Cortica Care CVS Ventures

bhbusiness.comOCT 2023

OCT 2023

Investment

Participated in Abridge's $30M round to accelerate generative AI adoption for clinical documentation.

Abridge

Abridge CVS Ventures

businesswire.comOCT 2023

OCT 2023

News

CVS Health launched a $100M dedicated corporate venture fund focused on digital health innovation.

CVS Health Ventures launches $100M fund

CVS Ventures

prnewswire.comMAY 2021

MAY 2021

CVS Ventures Activity

Participated in Oshi Health's $30M Series B for virtual multidisciplinary digestive care.

Participated in Main Street Health's $315M round for value-based care scaling in rural America.

Portfolio company Thyme Care achieved unicorn status in 2025, becoming CVS Health Ventures' most recent unicorn.

Strategic investment in Fathom, an autonomous medical coding platform achieving 90%+ automation rates across specialties.

Participated in Big Health's $23.7M round for FDA-cleared digital therapeutics including SleepioRx and DaylightRx.

Led Knownwell's oversubscribed $25M round to scale its weight-inclusive primary care and obesity medicine model nationwide.

Portfolio company Thirty Madison acquired by Remedy Meds for $500M.

Led AmplifAI's $33.7M Series B for AI-powered contact center performance platform.

Strategic investment in Amalgam Rx for patient and provider decision-making support.

Participated in Strive Health's $166M Series C for value-based kidney disease care.

Led Cortica's $40M Series D extension for doctor-led autism care services.

Participated in Abridge's $30M round to accelerate generative AI adoption for clinical documentation.

CVS Health launched a $100M dedicated corporate venture fund focused on digital health innovation.